BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28267561)

  • 1. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antihyperalgesic and antinociceptive effects of morphine and methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (MP-III-024): a positive allosteric modulator at α2GABA
    Rahman MA; Keck TM; Poe MM; Sharmin D; Cook JM; Fischer BD
    Psychopharmacology (Berl); 2021 Jun; 238(6):1585-1592. PubMed ID: 33585961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA
    Berro LF; Rüedi-Bettschen D; Cook JE; Golani LK; Li G; Jahan R; Rashid F; Cook JM; Rowlett JK; Platt DM
    Alcohol Clin Exp Res; 2019 May; 43(5):791-802. PubMed ID: 30861153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis.
    Fischer BD; Platt DM; Rallapalli SK; Namjoshi OA; Cook JM; Rowlett JK
    Drug Alcohol Depend; 2016 Jan; 158():22-9. PubMed ID: 26596587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.
    Rowlett JK; Platt DM; Lelas S; Atack JR; Dawson GR
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):915-20. PubMed ID: 15644443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABA
    Stamenić TT; Poe MM; Rehman S; Santrač A; Divović B; Scholze P; Ernst M; Cook JM; Savić MM
    Eur J Pharmacol; 2016 Nov; 791():433-443. PubMed ID: 27639297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The α2,3-selective potentiators of GABA
    Biggerstaff A; Kivell B; Smith JL; Mian MY; Golani LK; Rashid F; Sharmin D; Knutson DE; Cerne R; Cook JM; Witkin JM
    Pharmacol Biochem Behav; 2020 Sep; 196():172996. PubMed ID: 32668266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice.
    Knabl J; Zeilhofer UB; Crestani F; Rudolph U; Zeilhofer HU
    Pain; 2009 Feb; 141(3):233-238. PubMed ID: 19091469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states.
    Drexler B; Zinser S; Huang S; Poe MM; Rudolph U; Cook JM; Antkowiak B
    Eur J Pharmacol; 2013 Mar; 703(1-3):18-24. PubMed ID: 23380687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites.
    Paul J; Yévenes GE; Benke D; Di Lio A; Ralvenius WT; Witschi R; Scheurer L; Cook JM; Rudolph U; Fritschy JM; Zeilhofer HU
    Neuropsychopharmacology; 2014 Jan; 39(2):477-87. PubMed ID: 24045508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
    Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
    ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA
    Witkin JM; Smith JL; Ping X; Gleason SD; Poe MM; Li G; Jin X; Hobbs J; Schkeryantz JM; McDermott JS; Alatorre AI; Siemian JN; Cramer JW; Airey DC; Methuku KR; Tiruveedhula VVNPB; Jones TM; Crawford J; Krambis MJ; Fisher JL; Cook JM; Cerne R
    Neuropharmacology; 2018 Jul; 137():332-343. PubMed ID: 29778948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.
    Obradović ALj; Joksimović S; Poe MM; Ramerstorfer J; Varagic Z; Namjoshi O; Batinić B; Radulović T; Marković B; Roth BL; Sieghart W; Cook JM; Savić MM
    Brain Res; 2014 Mar; 1554():36-48. PubMed ID: 24472579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
    Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
    Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.
    Fischer BD; Licata SC; Edwankar RV; Wang ZJ; Huang S; He X; Yu J; Zhou H; Johnson EM; Cook JM; Furtmüller R; Ramerstorfer J; Sieghart W; Roth BL; Majumder S; Rowlett JK
    Neuropharmacology; 2010 Dec; 59(7-8):612-8. PubMed ID: 20727364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation.
    Fischer BD; Teixeira LP; van Linn ML; Namjoshi OA; Cook JM; Rowlett JK
    Psychopharmacology (Berl); 2013 May; 227(2):347-54. PubMed ID: 23354533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABA
    Meng Z; Berro LF; Sawyer EK; Rüedi-Bettschen D; Cook JE; Li G; Platt DM; Cook JM; Rowlett JK
    J Psychopharmacol; 2020 Mar; 34(3):348-357. PubMed ID: 31670615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.
    Ralvenius WT; Benke D; Acuña MA; Rudolph U; Zeilhofer HU
    Nat Commun; 2015 Apr; 6():6803. PubMed ID: 25865415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.